Dow Down0.90% Nasdaq Down1.42%

Array BioPharma Inc. (ARRY)

-NasdaqGM
2.52 Down 0.10(3.82%) 9:32AM EST - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2015Jun 30, 2014Jun 30, 2013
Total Revenue 51,909   42,078   69,580  
Cost of Revenue44,392  45,965  30,078  
Gross Profit 7,517   (3,887) 39,502  
Operating Expenses
Research Development54,442  49,824  59,420  
Selling General and Administrative31,433  21,907  19,624  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 3,293   (75,618) (39,542)
Income from Continuing Operations
Total Other Income/Expenses Net97,974  77  (11,142)
Earnings Before Interest And Taxes19,616  (75,541)(50,684)
Interest Expense10,247  9,716  11,258  
Income Before Tax9,369  (85,257)(61,942)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops9,369  (85,257)(73,139)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 9,369   (85,257) (61,942)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 9,369   (85,257) (61,942)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.